Annual Report

Overview

The report describes a strong 2006 performance, with revenue reaching R3,449 billion and continued growth across Aspen's pharmaceutical and consumer businesses. The company reports that its ARV products contributed to treatment for approximately 300 000 lives in sub-Saharan Africa. Its sustainability disclosures cover employment equity, skills development, health and safety, HIV/AIDS programmes, environmental management, ethics, and stakeholder engagement; 11 disabling injuries were reported across the Group during the year.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2006
Period: Ends 30 June 2006
Language: English
Pages
File size
Restatement: Disclosed

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services